Kymos Group

Kymos Group, an analytical CRO, specializes in bioanalysis and quality control of small molecules, biologics, and nucleic acids. Established in 2001, the company caters to various industries including pharmaceuticals, biotechnology, veterinary, fine chemistry, cosmetics, and nutraceuticals. Its services encompass a wide range of activities such as immunogenicity studies, immunoassays for biological drugs, bioanalysis in preclinical and clinical studies, bioequivalence studies, quality control, stability studies, and analytical development of drug substances and products. Moreover, Kymos offers process analytical technology services using NIR and RAMAN, along with QbD strategies. The company is certified in compliance with GLP's and GMP's and has been authorized as a partial manufacturer in quality control. As of now, there is no available information regarding the last investment or the investors involved.